2-[4-[3-tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-(3,4-dimethyl-5-phenylphenyl)benzimidazol-2-yl]phenol
C48H41N3O — CID 163682700
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[3-tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-(3,4-dimethyl-5-phenylphenyl)benzimidazol-2-yl]phenol
2-[4-[3-tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-(3,4-dimethyl-5-phenylphenyl)benzimidazol-2-yl]phenol (PubChem CID 163682700) has the molecular formula C48H41N3O and a molecular weight of 675.88 g/mol. Its IUPAC name is 2-[4-[3-tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-(3,4-dimethyl-5-phenylphenyl)benzimidazol-2-yl]phenol.
Molecular Properties
| Compound Name | 2-[4-[3-tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-(3,4-dimethyl-5-phenylphenyl)benzimidazol-2-yl]phenol |
|---|---|
| PubChem CID | 163682700 |
| Molecular Formula | C48H41N3O |
| Molecular Weight | 675.88 g/mol |
| Exact Mass | 675.32 |
| IUPAC Name | 2-[4-[3-tert-butyl-5-(4-phenyl-2-pyridinyl)phenyl]-1-(3,4-dimethyl-5-phenylphenyl)benzimidazol-2-yl]phenol |
| SMILES | Cc1cc(-n2c(-c3ccccc3O)nc3c(-c4cc(-c5cc(-c6ccccc6)ccn5)cc(C(C)(C)C)c4)cccc32)cc(-c2ccccc2)c1C |
| InChI | InChI=1S/C48H41N3O/c1-31-25-39(30-42(32(31)2)34-17-10-7-11-18-34)51-44-21-14-20-40(46(44)50-47(51)41-19-12-13-22-45(41)52)36-26-37(28-38(27-36)48(3,4)5)43-29-35(23-24-49-43)33-15-8-6-9-16-33/h6-30,52H,1-5H3 |
| InChIKey | LTBLYKSFXJTDGO-UHFFFAOYSA-N |
| XLogP | 12.38 |
| TPSA | 50.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 675.88 |
| LogP ≤ 5 | 12.38 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163682700 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.